ARTICLE | Company News
Innovir, Instituto di Richerche di Biologia Molecolare deal
September 16, 1996 7:00 AM UTC
INVR and the institute will conduct a feasibility study for new uses of INVR's site-specific External Guide Sequence (EGS) technology. EGS is a small RNA molecule engineered to bind to specific disease-causing RNA, creating a structure resembling the RNA molecule that is naturally cleaved by the ribozyme RNase P, which is found in every living cell. ...